Abstract Microdosing psychedelics has garnered considerable attention within both nonprofessional circles and the scientific community in recent years. This method involves taking small, non-hallucinogenic doses of substances like LSD or psilocybin over weeks or months, purportedly to enhance specific behaviors, emotions, or address psychiatric conditions. Exploring these assertions is crucial...
Introduction Recently, the pros and cons have been debating in Korea even before the approval of use of medical marijuana with very strict limitations. And the next controversial topic is psychedelics. In 1890, when mescaline was first isolated from peyote cactus, clinical researches began, but due to its harmful effects, it was thereafter legally prohibited in 1970 in USA. However, a...
Introduction Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and post-traumatic stress disorder. Objectives...
Abstract Alcohol use disorder (AUD) remains one of the most prevalent psychiatric disorders worldwide with high economic costs. Current treatment options show modest efficacy and relapse rates are high. Furthermore, there are increases in the treatment gap and few new medications have been approved in the past 20 years. Recently, psychedelic‐assisted therapy with psilocybin and lysergic acid...
The practice of microdosing classic psychedelic drugs (e.g. LSD [lysergic acid diethylamide] and psilocybin) has not only become more commonplace, but has also been shown to have potential in treating various psychological impairments. Much is still unknown about how people who microdose psychedelic drugs learn the processes and protocols for microdosing. To uncover how people learn the various...
Natural psychedelics such as magic mushrooms have a long history of human use of at least 7000 years. Their use underwent a resurgence in the 1950/1960s following the synthesis of LSD as a psychedelic and its use as a medicine with powerful therapeutic benefits. But because non-medical use led to massive cultural changes especially in young people, all psychedelics were banned globally in the...
Distributed by The Video Project, 145 - 9th St., Suite 230, San Francisco, CA 94103; 800-475-2638Produced by Adam GoldhammerDirected by Adam Goldhammer2023, Streaming, 45 mins Linda’s Last Trip is a heartfelt meditation into 64-year-old patient Linda Patchett’s terminal cancer diagnosis and her corresponding treatment with psilocybin mushrooms. Patchett’s journey delves into friendship, family,...
Medical training often fails to address the importance of culturally adapted tools and approaches that appreciate the beliefs and realities of patients influencing wellbeing, resilience patterns and intervention. The papers in this collection speak to value of integrating social and culture in both individual and community mental health engagement Transformative learning theory (TLT) (Mezirow...
The species of Gymnopilus (Hymenogastraceae, Agricales) are commonly recognized as wood-decaying fungi. Certain members of this genus have been identified as psilocybin-producing mushrooms. Gymnopilus exhibits a diverse range and has a global distribution. In this study, a total of seventy-eight specimens were gathered from ten provinces in China. A comprehensive molecular phylogenetic analysis...
The use of psychoactive substances for ritual, spiritual and medicinal purposes stretches back into prehistory and has been a common feature of many diverse cultures and societies globally. Psychedelics, with their unique ability to amplify feelings of connectedness and openness, may have also served as tools for promoting tribal cohesion and trust in ancient cultures. Psychedelic is a broad...